These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 3938597
1. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder]. Anton-Aparicio LM, Urmeneta J, Borras M, Balaguer R, Berián JM. Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597 [No Abstract] [Full Text] [Related]
2. Transitional explant reduction assay--a new in vitro testing system for intravesical chemotherapy. Weaver DJ, Barrett BA, Ross G, Adelstein EH. J Urol; 1986 Feb; 135(2):386-91. PubMed ID: 3080606 [Abstract] [Full Text] [Related]
3. Treatment of superficial carcinoma of the bladder. Paulson DF. Prog Clin Biol Res; 1984 Feb; 162B():193-209. PubMed ID: 6209720 [No Abstract] [Full Text] [Related]
8. Clinical trials in superficial and invasive bladder cancer. Smith PH. Turk J Pediatr; 1984 Aug; 26(1-4):251-63. PubMed ID: 6443168 [No Abstract] [Full Text] [Related]
9. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer. Seraphim LA, Perrapato SD, Slocum HK, Rustum YM, Huben RP. J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087 [Abstract] [Full Text] [Related]
10. In vitro drug sensitivity studies in human transitional cell carcinoma of the bladder. Konowalchuk TW, Elhilali M, Mackillop WJ. Cancer Lett; 1987 May; 35(2):181-90. PubMed ID: 3107798 [Abstract] [Full Text] [Related]
11. [Bladder cancer: chemotherapy of advanced bladder cancer]. Koiso K. Gan To Kagaku Ryoho; 1982 Mar; 9(3):377-86. PubMed ID: 6820897 [Abstract] [Full Text] [Related]
12. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin]. Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF. Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347 [No Abstract] [Full Text] [Related]
13. [Pretherapeutic testing of sensitivity to cytostatic drugs in primary cultures of selected urologic tumors]. Klatte D, Redmann K, Müller GW, Richter A, Gabriel D. Z Urol Nephrol; 1986 Aug; 79(8):441-7. PubMed ID: 2430377 [Abstract] [Full Text] [Related]
14. [Chemotherapy of bladder tumors]. Vallet D, Cappelaere P, Adenis L, Demaille A. Lille Med; 1978 Aug; 23(7):486-9. PubMed ID: 364222 [No Abstract] [Full Text] [Related]
17. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix. Parker RL, Welander CE, Homesley HD, Jobson VW, Kawamoto EH. Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571 [Abstract] [Full Text] [Related]
18. [Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test]. Gohji K, Okada Y, Hamami G, Kamidono S, Ishigami J, Murao S, Aogauchi R, Maeda S, Sugiyama T. Gan To Kagaku Ryoho; 1985 Jun; 12(6):1294-300. PubMed ID: 2408580 [Abstract] [Full Text] [Related]
19. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients]. Ohnoshi T, Hiraki S. Gan To Kagaku Ryoho; 1985 Aug; 12(8):1582-7. PubMed ID: 3927847 [Abstract] [Full Text] [Related]
20. Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro. Parris CN, Masters JR, Walker MC, Newman B, Riddle P, English P. Urol Res; 1987 Aug; 15(1):17-20. PubMed ID: 3103302 [Abstract] [Full Text] [Related] Page: [Next] [New Search]